3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol is a PEG-based ADC linker spacer improving hydrophilicity and flexibility in antibody-drug conjugates. It enhances solubility and pharmacokinetics of ADC payloads, optimizing targeted drug delivery.
Structure of 3055-99-0
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
NCT Number | Title | Condition Or Disease | Phase | Start Date | Sponsor | Status |
---|---|---|---|---|---|---|
NCT01185951 | TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies | Tendinopathy | Phase 2 | January 2007 | Hannover Medical School | Unknown status |
NCT02154789 | An Assessment of Intra-lesional 3% Polidocanol Solution in the Treatment of Digital Myxoid Cyst | Ganglion Cysts | Phase 4 | June 2014 | University of Edinburgh | Unknown status |
NCT02462720 | COMFORT: A Multicenter, Open-label, Randomized, Crossover Study | Varicose Veins | Phase 4 | May 2015 | BTG International Inc. | Completed |
NCT03257254 | Effect of VarIthena on Wound Healing in VLU | Venous Leg Ulcer | September 29, 2017 | Provensis Ltd | Recruiting |
3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol, a versatile polyethylene glycol (PEG) derivative, finds applications across scientific and industrial realms. Here are four key applications portrayed with a high degree of perplexity and burstiness:
Drug Delivery Systems: Embracing this PEG derivative, pharmaceutical formulations undergo a metamorphosis, enhancing solubility and stability of drugs. This transformation extends the circulation time of therapeutic agents in the bloodstream, elevating their biodistribution and efficacy. Moreover, the molecule's presence diminishes immunogenicity, amplifying the therapeutic index of biologic drugs to new heights of effectiveness.
Biomedical Research: Dive into bio-conjugation and surface modification with 3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol, a fundamental tool for functionalizing nanoparticles and diverse materials. By affixing this PEG derivative to surfaces, researchers navigate the realm of reduced non-specific binding, refining biocompatibility. This aspect is pivotal in the progression of biosensors, diagnostic tools, and a myriad of biomedical devices, accentuating precision and reliability.
Polymer Science: Positioned as a cornerstone in the synthesis of amphiphilic block copolymers, this PEG derivative unlocks realms of self-assembly into structures like micelles and vesicles in aqueous environments. These resulting materials become pioneers in drug delivery, wastewater treatment, and as emulsifying agents in multifarious industrial processes, ushering in an era of innovation and practicality.
Cosmetic Industry: Unveil the transformative prowess of 3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol in the cosmetic domain, serving as an emollient and humectant in skincare formulations. Its adeptness in moisture retention augments skin texture and hydration, nurturing a paradigm shift in skincare efficacy. Furthermore, as a solvent for active ingredients, this compound elevates their permeation and effectiveness in topical applications, paving the way for a new era of cosmetic excellence.
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.